{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:10:20Z","timestamp":1792699820845,"version":"4.5.0"},"reference-count":152,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T00:00:00Z","timestamp":1663027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.bioactmat.2022.09.009","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T12:39:00Z","timestamp":1668170340000},"page":"170-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Structural and temporal dynamics analysis on drug-eluting stents: History, research hotspots and emerging trends"],"prefix":"10.1016","volume":"23","author":[{"given":"Lili","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangxiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kungshan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tieying","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruolin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhirong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9192-8757","authenticated-orcid":false,"given":"Guixue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.bioactmat.2022.09.009_bib1","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa012843","article-title":"A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization","volume":"346","author":"Morice","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.bioactmat.2022.09.009_bib2","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/CIRCULATIONAHA.107.762047","article-title":"Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study","volume":"118","author":"Nakazawa","year":"2008","journal-title":"Circulation"},{"issue":"9591","key":"10.1016\/j.bioactmat.2022.09.009_bib3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":"Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis","volume":"370","author":"Stettler","year":"2007","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.bioactmat.2022.09.009_bib4","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1161\/01.CIR.0000127105.99982.21","article-title":"Stent thrombosis after successful sirolimus-eluting stent implantation","volume":"109","author":"Jeremias","year":"2004","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.bioactmat.2022.09.009_bib5","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jacc.2014.11.053","article-title":"Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates","volume":"65","author":"Valgimigli","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.bioactmat.2022.09.009_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2147\/vhrm.2008.04.01.31","article-title":"Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V)","volume":"4","author":"Sheiban","year":"2008","journal-title":"Vasc. Health Risk Manag."},{"issue":"1","key":"10.1016\/j.bioactmat.2022.09.009_bib7","first-page":"1","article-title":"Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions. Clinical and angiographic results of the ENDEAVOR II Trial","volume":"55","author":"Fajadet","year":"2007","journal-title":"Minerva Cardioangiol."},{"issue":"5","key":"10.1016\/j.bioactmat.2022.09.009_bib8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jcin.2010.12.014","volume":"4","author":"Kandzari","year":"2011","journal-title":"JACC Cardiovasc. Interv."},{"issue":"13","key":"10.1016\/j.bioactmat.2022.09.009_bib9","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/CIRCULATIONAHA.110.003210","article-title":"Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings","volume":"123","author":"Kolandaivelu","year":"2011","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.bioactmat.2022.09.009_bib10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.carrev.2015.06.009","article-title":"A comparison of drug eluting stent biocompatibility between third generation NOBORI biolimus A9-eluting stent and second generation XIENCE V everolimus-eluting stent in a porcine coronary artery model","volume":"16","author":"Sumida","year":"2015","journal-title":"Cardiovasc. Revascularization Med."},{"key":"10.1016\/j.bioactmat.2022.09.009_bib11","article-title":"First clinical evidence characterizing safety and efficacy of the new CoCr Biolimus-A9 eluting stent: the Biomatrix Alpha\u2122 registry","volume":"26","author":"Menown","year":"2020","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"5","key":"10.1016\/j.bioactmat.2022.09.009_bib12","first-page":"E132","article-title":"Two-year clinical outcomes of the NOBORI biolimus-eluting stents versus XIENCE\/PROMUS everolimus-eluting stents in small vessel disease","volume":"88","author":"Jinnouchi","year":"2016","journal-title":"Cathet. Cardiovasc. Interv."},{"issue":"5","key":"10.1016\/j.bioactmat.2022.09.009_bib13","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ihj.2013.08.031","article-title":"One-year clinical outcomes of BioMatrix\u2122-Biolimus A9\u2122 eluting stent: the e-BioMatrix multicenter post marketing surveillance registry in India","volume":"65","author":"Mehta","year":"2013","journal-title":"Indian Heart J."},{"issue":"6","key":"10.1016\/j.bioactmat.2022.09.009_bib14","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/CIRCINTERVENTIONS.110.946426","article-title":"Six-month results of the NEVO Res-Elution I (NEVO RES-I) trial: a randomized, multicenter comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Libert\u00e9 paclitaxel-eluting stent in de novo native coronary artery lesions","volume":"3","author":"Ormiston","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.bioactmat.2022.09.009_bib15","first-page":"408","article-title":"Reduced antiplatelet therapy after drug-eluting stenting: multicenter Janus Flex carbostent implantation with short dual antiplatelet treatment for 2 or 6 months-MATRIX study","volume":"80","author":"Cassese","year":"2012","journal-title":"Cathet. Cardiovasc. Interv."},{"issue":"25","key":"10.1016\/j.bioactmat.2022.09.009_bib16","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1161\/CIRCULATIONAHA.119.040556","article-title":"Polymer-free drug-eluting stents: the importance of the right control","volume":"141","author":"Colleran","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.bioactmat.2022.09.009_bib17","first-page":"666","article-title":"A TEMPOL and rapamycin loaded nanofiber-covered stent favors endothelialization and mitigates neointimal hyperplasia and local inflammation","volume":"19","author":"Wang","year":"2023","journal-title":"Bioact. Mater."},{"issue":"4","key":"10.1016\/j.bioactmat.2022.09.009_bib18","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1021\/acsbiomaterials.0c00041","article-title":"Photofunctionalized and drug-loaded TiO(2) nanotubes with improved vascular biocompatibility as a potential material for polymer-free drug-eluting stents","volume":"6","author":"Dai","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.bioactmat.2022.09.009_bib19","first-page":"144","article-title":"A surface-eroding poly(1,3-trimethylene carbonate) coating for magnesium based cardiovascular stents with stable drug release and improved corrosion resistance","volume":"7","author":"Tang","year":"2022","journal-title":"Bioact. Mater."},{"issue":"11","key":"10.1016\/j.bioactmat.2022.09.009_bib20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s10856-019-6324-9","article-title":"Systematical evolution on a Zn-Mg alloy potentially developed for biodegradable cardiovascular stents","volume":"30","author":"Lin","year":"2019","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.bioactmat.2022.09.009_bib21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.msec.2018.04.100","article-title":"Biodegradable stents for coronary artery disease treatment: recent advances and future perspectives","volume":"91","author":"Hu","year":"2018","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"4","key":"10.1016\/j.bioactmat.2022.09.009_bib22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/jbm.a.33066","article-title":"Layer-by-layer assembly of chitosan and platelet monoclonal antibody to improve biocompatibility and release character of PLLA coated stent","volume":"97","author":"Luo","year":"2011","journal-title":"J. Biomed. Mater. Res."},{"issue":"6","key":"10.1016\/j.bioactmat.2022.09.009_bib23","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/jbm.a.34078","article-title":"Endothelialization and in-stent restenosis on the surface of glycoprotein IIIa monoclonal antibody eluting stent","volume":"100","author":"Yin","year":"2012","journal-title":"J. Biomed. Mater. Res."},{"issue":"3","key":"10.1016\/j.bioactmat.2022.09.009_bib24","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/jbm.a.31369","article-title":"In-vitro assays of polymer-coated stents eluting platelet glycoprotein IIb\/IIIa receptor monoclonal antibody","volume":"83","author":"Yin","year":"2007","journal-title":"J. Biomed. Mater. Res."},{"issue":"11","key":"10.1016\/j.bioactmat.2022.09.009_bib25","doi-asserted-by":"crossref","first-page":"7578","DOI":"10.1021\/acsami.6b00152","article-title":"Re-endothelialization study on endovascular stents seeded by endothelial cells through up- or downregulation of VEGF","volume":"8","author":"Wu","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"6","key":"10.1016\/j.bioactmat.2022.09.009_bib26","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/jbm.b.34274","article-title":"Corrosion behavior and biocompatibility evaluation of a novel zinc-based alloy stent in rabbit carotid artery model","volume":"107","author":"Lin","year":"2019","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"issue":"2","key":"10.1016\/j.bioactmat.2022.09.009_bib27","first-page":"375","article-title":"A novel mechanism of inhibiting in-stent restenosis with arsenic trioxide drug-eluting stent: enhancing contractile phenotype of vascular smooth muscle cells via YAP pathway","volume":"6","author":"Zhao","year":"2021","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioactmat.2022.09.009_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.110187","article-title":"Covalent immobilization of biomolecules on stent materials through mussel adhesive protein coating to form biofunctional films","volume":"106","author":"Wang","year":"2020","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"7","key":"10.1016\/j.bioactmat.2022.09.009_bib29","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41427-018-0064-z","article-title":"Design and testing of hydrophobic core\/hydrophilic shell nano\/micro particles for drug-eluting stent coating","volume":"10","author":"Du","year":"2018","journal-title":"NPG Asia Mater."},{"issue":"1","key":"10.1016\/j.bioactmat.2022.09.009_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11051-009-9729-4","article-title":"Is there a shift to \"active nanostructures","volume":"12","author":"Subramanian","year":"2010","journal-title":"J. Nano Res."},{"issue":"3","key":"10.1016\/j.bioactmat.2022.09.009_bib31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s13337-016-0339-3","article-title":"Scientometric analysis of research on Zika virus","volume":"27","author":"Singh","year":"2016","journal-title":"Virusdisease"},{"key":"10.1016\/j.bioactmat.2022.09.009_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.impact.2021.100316","article-title":"Engineered nanomaterials for (waste)water treatment - a scientometric assessment and sustainability aspects","volume":"22","author":"Davarazar","year":"2021","journal-title":"NanoImpact"},{"key":"10.1016\/j.bioactmat.2022.09.009_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2021.113932","article-title":"Frontier and hot topics in electrochemiluminescence sensing technology based on CiteSpace bibliometric analysis","volume":"201","author":"Liu","year":"2022","journal-title":"Biosens. Bioelectron."},{"issue":"1","key":"10.1016\/j.bioactmat.2022.09.009_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19010026","article-title":"Citation network study on the use of new technologies in neurorehabilitation","volume":"19","author":"Abu\u00edn-Porras","year":"2021","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.bioactmat.2022.09.009_bib35","article-title":"Bibliometric analysis of the inflammasome and pyroptosis in brain","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioactmat.2022.09.009_bib36","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.5808\/gi.21083","article-title":"Publication trends of somatic mutation and recombination tests research: a bibliometric analysis (1984\u20122020)","volume":"20","author":"Tagorti","year":"2022","journal-title":"Genomics Inform"},{"issue":"suppl","key":"10.1016\/j.bioactmat.2022.09.009_bib37","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.1073\/pnas.0307513100","article-title":"Searching for intellectual turning points: progressive knowledge domain visualization","volume":"101","author":"Chen","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.bioactmat.2022.09.009_bib38","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1023\/A:1024940629314","article-title":"Bursty and hierarchical structure in streams","volume":"4","author":"Kleinberg","year":"2003","journal-title":"Data mining and know;edge discovery"},{"issue":"3","key":"10.1016\/j.bioactmat.2022.09.009_bib39","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/asi.20317","article-title":"CiteSpace II: detecting and visualizing emerging trends and transient patterns in scientific literature","volume":"57","author":"Chen","year":"2006","journal-title":"J. Am. Soc. Inf. Sci. Technol."},{"issue":"7","key":"10.1016\/j.bioactmat.2022.09.009_bib40","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/asi.21309","article-title":"The structure and dynamics of cocitation clusters: a multiple-perspective cocitation analysis","volume":"61","author":"Chen","year":"2010","journal-title":"J. Am. Soc. Inf. Sci. Technol."},{"issue":"9","key":"10.1016\/j.bioactmat.2022.09.009_bib41","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1517\/14712598.2014.920813","article-title":"Emerging trends and new developments in regenerative medicine: a scientometric update (2000 - 2014)","volume":"14","author":"Chen","year":"2014","journal-title":"Expet Opin. Biol. Ther."},{"issue":"1","key":"10.1016\/j.bioactmat.2022.09.009_bib42","doi-asserted-by":"crossref","first-page":"e8694","DOI":"10.1371\/journal.pone.0008694","article-title":"Mapping change in large networks","volume":"5","author":"Rosvall","year":"2010","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.bioactmat.2022.09.009_bib43","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"Moses","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.bioactmat.2022.09.009_bib44","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents","volume":"293","author":"Iakovou","year":"2005","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.bioactmat.2022.09.009_bib45","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.bioactmat.2022.09.009_bib46","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa032441","article-title":"A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease","volume":"350","author":"Stone","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.bioactmat.2022.09.009_bib47","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa067193","article-title":"Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents","volume":"356","author":"Stone","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.bioactmat.2022.09.009_bib48","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/01.CIR.0000116202.41966.D4","article-title":"Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?","volume":"109","author":"Virmani","year":"2004","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.bioactmat.2022.09.009_bib49","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.107.693739","article-title":"Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization","volume":"115","author":"Finn","year":"2007","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.bioactmat.2022.09.009_bib50","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1056\/NEJMoa067731","article-title":"Stent thrombosis in randomized clinical trials of drug-eluting stents","volume":"356","author":"Mauri","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.bioactmat.2022.09.009_bib51","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa067722","article-title":"Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden","volume":"356","author":"Lagerqvist","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"9444","key":"10.1016\/j.bioactmat.2022.09.009_bib52","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(04)17275-9","article-title":"Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy","volume":"364","author":"McFadden","year":"2004","journal-title":"Lancet"},{"issue":"9824","key":"10.1016\/j.bioactmat.2022.09.009_bib53","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(12)60324-9","article-title":"Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis","volume":"379","author":"Palmerini","year":"2012","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.bioactmat.2022.09.009_bib54","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/01.CIR.0000086926.62288.A6","article-title":"Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions","volume":"108","author":"Colombo","year":"2003","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.bioactmat.2022.09.009_bib55","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jacc.2011.01.011","article-title":"The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents","volume":"57","author":"Nakazawa","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"18","key":"10.1016\/j.bioactmat.2022.09.009_bib56","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.106.658237","article-title":"Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation","volume":"115","author":"Cook","year":"2007","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.bioactmat.2022.09.009_bib57","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa066633","article-title":"A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents","volume":"356","author":"Spaulding","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bioactmat.2022.09.009_bib58","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa1004130","article-title":"Comparison of zotarolimus-eluting and everolimus-eluting coronary stents","volume":"363","author":"Serruys","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bioactmat.2022.09.009_bib59","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jacc.2008.04.030","article-title":"Endothelial cell recovery between comparator polymer-based drug-eluting stents","volume":"52","author":"Joner","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"23","key":"10.1016\/j.bioactmat.2022.09.009_bib60","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bioactmat.2022.09.009_bib61","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/01.CIR.0000047700.58683.A1","article-title":"Taxus I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions","volume":"107","author":"Grube","year":"2003","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.bioactmat.2022.09.009_bib62","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1161\/CIRCULATIONAHA.108.839282","article-title":"Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis","volume":"119","author":"Unverdorben","year":"2009","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.bioactmat.2022.09.009_bib63","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1161\/01.CIR.0000118474.71662.E3","article-title":"Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions","volume":"109","author":"Colombo","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.bioactmat.2022.09.009_bib64","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.293.2.165","article-title":"Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial","volume":"293","author":"Kastrati","year":"2005","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.bioactmat.2022.09.009_bib65","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1161\/CIRCULATIONAHA.111.071589","article-title":"Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial","volume":"125","author":"Valgimigli","year":"2012","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.bioactmat.2022.09.009_bib66","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.jacc.2004.09.079","article-title":"Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation","volume":"45","author":"Ong","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.bioactmat.2022.09.009_bib67","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa0706356","article-title":"Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg","volume":"358","author":"Tepe","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bioactmat.2022.09.009_bib68","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/CIRCULATIONAHA.109.854398","article-title":"Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis","volume":"120","author":"Cook","year":"2009","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.bioactmat.2022.09.009_bib69","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jacc.2008.07.006","article-title":"Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study","volume":"52","author":"Wenaweser","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"15","key":"10.1016\/j.bioactmat.2022.09.009_bib70","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.jacc.2012.06.043","article-title":"A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)","volume":"60","author":"Kim","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.bioactmat.2022.09.009_bib71","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/CIRCULATIONAHA.111.059022","article-title":"Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience\/Promus versus Cypher to Reduce Late Loss after Stenting (EXCELLENT) randomized, multicenter study","volume":"125","author":"Gwon","year":"2012","journal-title":"Circulation"},{"issue":"9390","key":"10.1016\/j.bioactmat.2022.09.009_bib72","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(03)14462-5","article-title":"Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS)","volume":"362","author":"Schofer","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bioactmat.2022.09.009_bib73","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.bioactmat.2022.09.009_bib74","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1056\/NEJMoa067484","article-title":"Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents","volume":"356","author":"Kastrati","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"9562","key":"10.1016\/j.bioactmat.2022.09.009_bib75","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","article-title":"Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study","volume":"369","author":"Daemen","year":"2007","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.bioactmat.2022.09.009_bib76","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa0910496","article-title":"Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease","volume":"362","author":"Stone","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"9710","key":"10.1016\/j.bioactmat.2022.09.009_bib77","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(09)62127-9","article-title":"Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial","volume":"375","author":"Kedhi","year":"2010","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.bioactmat.2022.09.009_bib78","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","article-title":"ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention. A report of the American college of cardiology foundation\/American heart association task force on practice guidelines and the society for cardiovascular angiography and interventions","volume":"58","author":"Levine","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.bioactmat.2022.09.009_bib79","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/ejcts\/ezu366","volume":"46","author":"Kolh","year":"2014","journal-title":"Eur. J. Cardio. Thorac. Surg."},{"issue":"10","key":"10.1016\/j.bioactmat.2022.09.009_bib80","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jacc.2016.03.513","article-title":"ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"68","author":"Levine","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.bioactmat.2022.09.009_bib81","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","volume":"39","author":"Valgimigli","year":"2017","journal-title":"Eur. Heart J."},{"issue":"12","key":"10.1016\/j.bioactmat.2022.09.009_bib82","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1097\/HJH.0000000000001961","article-title":"Practice guidelines for the management of arterial hypertension of the European society of hypertension and the European society of cardiology: ESH\/ESC task force for the management of arterial hypertension","volume":"36","author":"Williams","year":"2018","journal-title":"J. Hypertens."},{"issue":"21","key":"10.1016\/j.bioactmat.2022.09.009_bib83","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1056\/NEJMoa1503943","article-title":"Polymer-free drug-coated coronary stents in patients at high bleeding risk","volume":"373","author":"Urban","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bioactmat.2022.09.009_bib84","doi-asserted-by":"crossref","first-page":"229","DOI":"10.5603\/KP.2018.0041","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.]","volume":"76","author":"Ibanez","year":"2017","journal-title":"Kardiol. Pol."},{"issue":"13","key":"10.1016\/j.bioactmat.2022.09.009_bib85","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1056\/NEJMoa1607991","article-title":"Drug-eluting or bare-metal stents for coronary artery disease","volume":"375","author":"B\u00f8naa","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.bioactmat.2022.09.009_bib86","doi-asserted-by":"crossref","first-page":"e011245","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J. Am. Heart Assoc."},{"issue":"20","key":"10.1016\/j.bioactmat.2022.09.009_bib87","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1509038","article-title":"Everolimus-eluting bioresorbable scaffolds for coronary artery disease","volume":"373","author":"Ellis","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.bioactmat.2022.09.009_bib88","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.jacc.2015.04.017","article-title":"Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis","volume":"65","author":"Palmerini","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10059","key":"10.1016\/j.bioactmat.2022.09.009_bib89","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/S0140-6736(16)32050-5","article-title":"Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial","volume":"388","author":"Serruys","year":"2016","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.bioactmat.2022.09.009_bib90","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1056\/NEJMoa1610227","article-title":"Everolimus-eluting stents or bypass surgery for left main coronary artery disease","volume":"375","author":"Stone","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.bioactmat.2022.09.009_bib91","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.2016.3775","article-title":"Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 Year after percutaneous coronary intervention","volume":"315","author":"Yeh","year":"2016","journal-title":"JAMA"},{"issue":"9962","key":"10.1016\/j.bioactmat.2022.09.009_bib92","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(14)61455-0","volume":"385","author":"Serruys","year":"2015","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.bioactmat.2022.09.009_bib93","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"Bonaca","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"10105","key":"10.1016\/j.bioactmat.2022.09.009_bib94","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(17)32249-3","article-title":"Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial","volume":"390","author":"Kandzari","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bioactmat.2022.09.009_bib95","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.bioactmat.2022.09.009_bib96","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/eurheartj\/ehu523","article-title":"ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting","volume":"36","author":"Schulz-Sch\u00fcpke","year":"2015","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.bioactmat.2022.09.009_bib97","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jacc.2015.04.063","article-title":"A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents: the RIBS IV randomized clinical trial","volume":"66","author":"Alfonso","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"32","key":"10.1016\/j.bioactmat.2022.09.009_bib98","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1093\/eurheartj\/ehv205","article-title":"Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment","volume":"36","author":"Otsuka","year":"2015","journal-title":"Eur. Heart J."},{"issue":"24","key":"10.1016\/j.bioactmat.2022.09.009_bib99","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa1614954","article-title":"Bioresorbable scaffolds versus metallic stents in routine PCI","volume":"376","author":"Wykrzykowska","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.bioactmat.2022.09.009_bib100","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s12471-018-1113-5","article-title":"Optimal duration of dual antiplatelet therapy for coronary artery disease","volume":"26","author":"Kikkert","year":"2018","journal-title":"Neth. Heart J."},{"issue":"9","key":"10.1016\/j.bioactmat.2022.09.009_bib101","first-page":"781","article-title":"Optimal duration of dual antiplatelet therapy followed by monotherapy in diabetic patients after percutaneous coronary intervention with drug-eluting stent implantation: a Bayesian network meta-analysis","volume":"131","author":"An","year":"2021","journal-title":"Pol. Arch. Intern. Med."},{"issue":"17","key":"10.1016\/j.bioactmat.2022.09.009_bib102","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.4244\/EIJ-D-16-00093","article-title":"A novel constrained, paclitaxel-coated angioplasty balloon catheter","volume":"12","author":"Cremers","year":"2017","journal-title":"EuroIntervention"},{"issue":"19","key":"10.1016\/j.bioactmat.2022.09.009_bib103","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jcin.2018.05.041","article-title":"A randomized trial to assess regional left ventricular function after stent implantation in chronic total occlusion: the REVASC trial","volume":"11","author":"Mashayekhi","year":"2018","journal-title":"JACC Cardiovasc. Interv."},{"issue":"1","key":"10.1016\/j.bioactmat.2022.09.009_bib104","doi-asserted-by":"crossref","first-page":"283","DOI":"10.21037\/qims.2019.11.15","article-title":"Percutaneous mechanical atherothrombectomy using the Rotarex(\u00ae)S device in peripheral artery in-stent restenosis or occlusion: a French retrospective multicenter study on 128 patients","volume":"10","author":"Loffroy","year":"2020","journal-title":"Quant. Imag. Med. Surg."},{"issue":"Suppl 2","key":"10.1016\/j.bioactmat.2022.09.009_bib105","first-page":"1048","article-title":"Prognostic value of quantitative flow ratio measured immediately after drug-coated balloon angioplasty for in-stent restenosis","volume":"97","author":"Cai","year":"2021","journal-title":"Cathet. Cardiovasc. Interv."},{"issue":"10060","key":"10.1016\/j.bioactmat.2022.09.009_bib106","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/S0140-6736(16)31920-1","article-title":"Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial","volume":"388","author":"von Birgelen","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bioactmat.2022.09.009_bib107","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s00380-013-0450-y","article-title":"Natural history of low-intensity neointimal tissue after an everolimus-eluting stent implantation: a serial observation with optical coherence tomography","volume":"30","author":"Shibuya","year":"2015","journal-title":"Heart Ves."},{"issue":"4","key":"10.1016\/j.bioactmat.2022.09.009_bib108","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.mjafi.2016.09.002","article-title":"Drug eluting stents: to evolve or dissolve?","volume":"72","author":"Bharadwaj","year":"2016","journal-title":"Med. J. Armed Forces India"},{"key":"10.1016\/j.bioactmat.2022.09.009_bib109","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijcard.2016.09.045","article-title":"A review of the coronary applications of the drug coated balloon","volume":"226","author":"Jackson","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bioactmat.2022.09.009_bib110","series-title":"Systematic Review and Meta-Analysis of the Outcomes of Drug-Eluting Stent versus Drug-Coated Balloon Angioplasty for Lower Extremity Peripheral Artery Diseases","author":"Wang","year":"2022"},{"issue":"4","key":"10.1016\/j.bioactmat.2022.09.009_bib111","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.31083\/j.rcm2204147","article-title":"Back to the future: the role of DCB for the treatment of coronary bifurcation","volume":"22","author":"Buono","year":"2021","journal-title":"Rev. Cardiovasc. Med."},{"issue":"9","key":"10.1016\/j.bioactmat.2022.09.009_bib112","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.carrev.2018.11.019","article-title":"Potent stent-less procedure using rotational atherectomy and drug-coated balloon to right coronary ostial lesion","volume":"20","author":"Shiraishi","year":"2019","journal-title":"Cardiovasc. Revascularization Med."},{"issue":"1","key":"10.1016\/j.bioactmat.2022.09.009_bib113","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s43044-020-00116-7","article-title":"Drug-eluting balloon: is it useful?","volume":"72","author":"Laksono","year":"2020","journal-title":"Egypt Heart J"},{"issue":"23 Pt A","key":"10.1016\/j.bioactmat.2022.09.009_bib114","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1016\/j.jacc.2018.09.057","article-title":"ACC\/AHA versus ESC guidelines on dual antiplatelet therapy: JACC guideline comparison","volume":"72","author":"Capodanno","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4\u20135","key":"10.1016\/j.bioactmat.2022.09.009_bib115","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.pcad.2017.12.004","article-title":"Evolution of coronary stent technology and implications for duration of dual antiplatelet therapy","volume":"60","author":"Moon","year":"2018","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"6","key":"10.1016\/j.bioactmat.2022.09.009_bib116","doi-asserted-by":"crossref","first-page":"717","DOI":"10.4244\/EIJ-D-17-00468","article-title":"State of the art: duration of dual antiplatelet therapy after percutaneous coronary intervention and coronary stent implantation - past, present and future perspectives","volume":"13","author":"Gargiulo","year":"2017","journal-title":"EuroIntervention"},{"issue":"4","key":"10.1016\/j.bioactmat.2022.09.009_bib117","doi-asserted-by":"crossref","first-page":"64","DOI":"10.18087\/cardio.2022.4.n2020","article-title":"The role of platelet glycoprotein IIb\/IIIa inhibitors in current treatment of acute coronary syndrome","volume":"62","author":"Sukhinina","year":"2022","journal-title":"Kardiologiia"},{"issue":"1","key":"10.1016\/j.bioactmat.2022.09.009_bib118","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1002\/hsr2.105","article-title":"Vascular response and intrastent thrombus in the early phase after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: an observational, single-center study","volume":"2","author":"Sato","year":"2019","journal-title":"Health Sci Rep"},{"issue":"2","key":"10.1016\/j.bioactmat.2022.09.009_bib119","first-page":"E213","article-title":"Single antiplatelet therapy with use of prasugrel in patients undergoing percutaneous coronary intervention","volume":"98","author":"Otsuka","year":"2021","journal-title":"Cathet. Cardiovasc. Interv."},{"issue":"11","key":"10.1016\/j.bioactmat.2022.09.009_bib120","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1080\/14779072.2017.1386098","article-title":"Revisiting the role of durable polymers in cardiovascular devices","volume":"15","author":"Mori","year":"2017","journal-title":"Expert Rev. Cardiovasc Ther."},{"issue":"2","key":"10.1016\/j.bioactmat.2022.09.009_bib121","doi-asserted-by":"crossref","first-page":"215","DOI":"10.23736\/S2724-5683.20.05184-1","article-title":"The coronary resorbable magnesium scaffold Magmaris\u00ae: what we have learnt (so far\u2026)","volume":"69","author":"Bennett","year":"2021","journal-title":"Minerva Cardiol Angiol"},{"key":"10.1016\/j.bioactmat.2022.09.009_bib122","first-page":"378","article-title":"Two-stage degradation and novel functional endothelium characteristics of a 3-D printed bioresorbable scaffold","volume":"10","author":"Yin","year":"2022","journal-title":"Bioact. Mater."},{"issue":"10317","key":"10.1016\/j.bioactmat.2022.09.009_bib123","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/S0140-6736(21)02248-0","article-title":"Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial","volume":"398","author":"Xu","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.bioactmat.2022.09.009_bib124","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00380-019-01545-4","article-title":"Relationship of quantitative flow ratio after second-generation drug-eluting stent implantation to clinical outcomes","volume":"35","author":"Suzuki","year":"2020","journal-title":"Heart Ves."},{"issue":"2","key":"10.1016\/j.bioactmat.2022.09.009_bib125","first-page":"398","article-title":"Biodegradation behavior of micro-arc oxidation coating on magnesium alloy-from a protein perspective","volume":"5","author":"Zhang","year":"2020","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioactmat.2022.09.009_bib126","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.actbio.2015.04.011","article-title":"Recommendation for modifying current cytotoxicity testing standards for biodegradable magnesium-based materials","volume":"21","author":"Wang","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioactmat.2022.09.009_bib127","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.msec.2018.05.005","article-title":"Processing and properties of magnesium alloy micro-tubes for biodegradable vascular stents","volume":"90","author":"Wang","year":"2018","journal-title":"Mater. Sci. Eng. C"},{"issue":"11","key":"10.1016\/j.bioactmat.2022.09.009_bib128","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1039\/d0mt00151a","article-title":"Effect of degradation products of iron-bioresorbable implants on the physiological behavior of macrophages in vitro","volume":"12","author":"Fagali","year":"2020","journal-title":"Metallomics"},{"key":"10.1016\/j.bioactmat.2022.09.009_bib129","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.colsurfb.2015.02.047","article-title":"Cytotoxicity of corrosion products of degradable Fe-based stents: relevance of pH and insoluble products","volume":"128","author":"Fagali","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.bioactmat.2022.09.009_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.corsci.2021.109606","article-title":"Exploring the biodegradation of pure Zn under simulated inflammatory condition","volume":"189","author":"Liu","year":"2021","journal-title":"Corrosion Sci."},{"key":"10.1016\/j.bioactmat.2022.09.009_bib131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2018.03.005","article-title":"Zinc-based alloys for degradable vascular stent applications","volume":"71","author":"Mostaed","year":"2018","journal-title":"Acta Biomater."},{"issue":"7","key":"10.1016\/j.bioactmat.2022.09.009_bib132","doi-asserted-by":"crossref","first-page":"6809","DOI":"10.1021\/acsami.8b20634","article-title":"Mechanical strength, biodegradation, and in vitro and in vivo biocompatibility of Zn biomaterials","volume":"11","author":"Zhu","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"9","key":"10.1016\/j.bioactmat.2022.09.009_bib133","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/01.CIR.0000121327.67756.19","article-title":"Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis","volume":"109","author":"Fujii","year":"2004","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.bioactmat.2022.09.009_bib134","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.jacc.2011.10.903","article-title":"Role of endothelial shear stress in stent restenosis and thrombosis: pathophysiologic mechanisms and implications for clinical translation","volume":"59","author":"Koskinas","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"16","key":"10.1016\/j.bioactmat.2022.09.009_bib135","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1161\/CIRCULATIONAHA.105.536268","article-title":"Genetic inflammatory factors predict restenosis after percutaneous coronary interventions","volume":"112","author":"Monraats","year":"2005","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.bioactmat.2022.09.009_bib136","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/humu.20641","article-title":"Platelet receptor P2RY12 haplotypes predict restenosis after percutaneous coronary interventions","volume":"29","author":"Rudez","year":"2008","journal-title":"Hum. Mutat."},{"issue":"6","key":"10.1016\/j.bioactmat.2022.09.009_bib137","doi-asserted-by":"crossref","first-page":"e007822","DOI":"10.1161\/CIRCINTERVENTIONS.119.007822","article-title":"Risk factors and long-term clinical outcomes of second-generation drug-eluting stent thrombosis","volume":"12","author":"Kuramitsu","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.bioactmat.2022.09.009_bib138","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/CIRCINTERVENTIONS.113.000945","article-title":"Early aneurysm formation after everolimus-eluting stent implantation","volume":"7","author":"Kadakia","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"issue":"12","key":"10.1016\/j.bioactmat.2022.09.009_bib139","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.amjcard.2008.02.053","article-title":"Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial)","volume":"101","author":"Costa","year":"2008","journal-title":"Am. J. Cardiol."},{"issue":"8","key":"10.1016\/j.bioactmat.2022.09.009_bib140","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1253\/circj.CJ-10-0025","article-title":"Intravascular ultrasound criteria for determination of optimal longitudinal positioning of sirolimus-eluting stents","volume":"74","author":"Morino","year":"2010","journal-title":"Circ. J."},{"issue":"10","key":"10.1016\/j.bioactmat.2022.09.009_bib141","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.116.004231","article-title":"Optical coherence tomography predictors for edge restenosis after everolimus-eluting stent implantation","volume":"9","author":"Ino","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"issue":"Suppl 3","key":"10.1016\/j.bioactmat.2022.09.009_bib142","first-page":"98","article-title":"Influence of stent design and deployment technique on neointima formation and vascular remodeling","volume":"91","author":"K\u00f6nig","year":"2002","journal-title":"Z. Kardiol."},{"issue":"2","key":"10.1016\/j.bioactmat.2022.09.009_bib143","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10439-015-1373-9","article-title":"Design optimisation of coronary artery stent systems","volume":"44","author":"Bressloff","year":"2016","journal-title":"Ann. Biomed. Eng."},{"issue":"6","key":"10.1016\/j.bioactmat.2022.09.009_bib144","doi-asserted-by":"crossref","first-page":"e3453","DOI":"10.1002\/cnm.3453","article-title":"Surrogate-based multi-objective design optimization of a coronary stent: altering geometry toward improved biomechanical performance","volume":"37","author":"Ribeiro","year":"2021","journal-title":"Int J Numer Method Biomed Eng"},{"issue":"1","key":"10.1016\/j.bioactmat.2022.09.009_bib145","article-title":"Patient-specific computational simulation of coronary artery bifurcation stenting","volume":"11","author":"Zhao","year":"2021","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.bioactmat.2022.09.009_bib146","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jcin.2021.01.033","article-title":"Prediction of coronary stent underexpansion by pre-procedural intravascular ultrasound-based deep learning","volume":"14","author":"Min","year":"2021","journal-title":"JACC Cardiovasc. Interv."},{"issue":"8","key":"10.1016\/j.bioactmat.2022.09.009_bib147","doi-asserted-by":"crossref","first-page":"e007023","DOI":"10.1161\/CIRCINTERVENTIONS.118.007023","article-title":"Restenosis of drug-eluting stents: a new classification system based on disease mechanism to guide treatment and state-of-the-art review","volume":"12","author":"Shlofmitz","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"issue":"8","key":"10.1016\/j.bioactmat.2022.09.009_bib148","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1161\/CIRCULATIONAHA.106.675934","article-title":"Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications","volume":"115","author":"L\u00fcscher","year":"2007","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.bioactmat.2022.09.009_bib149","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/rb\/rby006","article-title":"Endovascular stent-induced alterations in host artery mechanical environments and their roles in stent restenosis and late thrombosis","volume":"5","author":"Wang","year":"2018","journal-title":"Regen Biomater"},{"key":"10.1016\/j.bioactmat.2022.09.009_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.apsusc.2019.144085","article-title":"Preparation, evaluation and functionalization of biomimetic block copolymer coatings for potential applications in cardiovascular implants","volume":"502","author":"Li","year":"2020","journal-title":"Appl. Surf. Sci."},{"issue":"11","key":"10.1016\/j.bioactmat.2022.09.009_bib151","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201700008","article-title":"3D-Printed multidrug-eluting stent from graphene-nanoplatelet-doped biodegradable polymer composite","volume":"6","author":"Misra","year":"2017","journal-title":"Adv Healthc Mater"},{"issue":"19","key":"10.1016\/j.bioactmat.2022.09.009_bib152","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.jacc.2020.03.011","article-title":"Ticagrelor with or without aspirin after complex PCI","volume":"75","author":"Dangas","year":"2020","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X22003929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X22003929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T14:37:57Z","timestamp":1762785477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X22003929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":152,"alternative-id":["S2452199X22003929"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2022.09.009","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural and temporal dynamics analysis on drug-eluting stents: History, research hotspots and emerging trends","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2022.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by KeAi Communications Co., Ltd.","name":"copyright","label":"Copyright"}]}}